Breast Cancer

A combination of two well known breast cancer drugs could prove very successful when treating hormone receptor-positive, HER2-positive metastatic disease.

A look at how two-time breast cancer survivor Joan Venticinque got her start in advocacy and where she thinks the future may take her.

A brief discussing findings from this year's San Antonio Breast Cancer Symposium showing that research suggests that the drug Zometa may provide patients with reduced bone loss and a lesser chance of recurrence.

A brief discussing investigation agent RAD001 (everolimus), a drug currently approved to treat kidney cancer, and the findings that now show the drug may be used to treat breast cancer.

A brief discussing the data from the NOAH trial in which Herceptin was added to chemotherapy before surgery for HER2-positive locally advanced breast cancer.

CURE Editor-in-Chief Debu Tripathy, MD, blogs on medical issues from SABCS.

CURE publisher Susan McClure blogs from a survivor's perspective.

An overview of the Susan G. Komen for the Cure awards held at this year's San Antonio Breast Cancer Symposium.

News from SABCS: Aromatase inhibitors are more effective than tamoxifen.

A brief look at how micrometasteses of the breast are being treated and the results from the MIRROR study which looked at whether or not micrometastases are predictive of recurrence.

CURE Editor-in-Chief Debu Tripathy, MD, blogs on medical issues from SABCS.

A brief summary of the role estrogen plays in helping treat breast cancer patients who are initially resistant to aromatase inhibitors.

Advocate Joan Venticinque blogs about patient advocacy.

The American Association of Cancer Research has joined the Cancer Therapy Research Center at the University of Texas Health Science Center at San Antonio, and the Baylor College of Medicine in putting on this year's San Antonio Breast Cancer Symposium.

Patient advocates lend a strong voice to this year’s San Antonio Breast Cancer Symposium.

A synopsis of last year's San Antonio Breast Cancer Symposium updates.

A look at the Triple Negative Breast Cancer Foundation’s roots and how the organization plans to expand their presence by funding necessary research and demanding that triple-negative breast cancer does not go unnoticed.

Advocate Joan Venticinque blogs about patient advocacy.

CURE publisher Susan McClure blogs from a survivor's perspective.

CURE Editor-in-Chief Debu Tripathy, MD, blogs on medical issues from SABCS.

Overview of education sessions during opening of SABCS.

New colorectal cancer screening gets high marks.

The validity of performing monthly breast self-exams to improve survival rates is again being questioned.

Controlling lymphedema with the old and the new.

Funding for lymphedema research is desperately needed.

Predicting drug response in colorectal cancer.

KRAS gene mutations are detected in various cancers, including colorectal.

A timeline of KRAS research.

Issues after surgery can be taxing for patient and caregiver.

Breast cancer survivors find a constructive outlet for their altruism.